POEMS Syndrome: Clinical Trials

3 trials for POEMS Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 1, Recruiting 1, Unknown 1

Follow POEMS Syndrome: new trials by email Literature Review of POEMS Syndrome trials Research Report on POEMS Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis
CD19/BCMA CAR T-cells - POEMS Syndrome, Amyloidosis
Early Phase 1UnknownZhejiang University752021-10-082022-03-03
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
CT103A cells, Cyclophosphamide and fludarabine - Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Early Phase 1RecruitingTongji Hospital362020-09-222024-10-30
Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome
Dexamethasone, Ixazomib Citrate, Lenalidomide - Plasmacytoma, POEMS Syndrome
Early Phase 1CompletedMayo Clinic212016-10-312025-02-12

Narrower conditions

Amyloidosis (1)  ·  Anemia, Hemolytic, Autoimmune (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Multiple Sclerosis (1)  ·  Myasthenia Gravis (1)  ·  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1)  ·  Myositis (1)  ·  Neuromyelitis Optica (1)  ·  Plasmacytoma (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)  ·  Vasculitis (1)

Broader conditions

Abnormalities, Multiple (3)  ·  Blood Protein Disorders (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Nervous System Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Paraproteinemias (3)  ·  Peripheral Nervous System Diseases (3)  ·  Polyneuropathies (3)  ·  Neoplasms (2)  ·  Anemia (1)

Interventions

Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Lenalidomide (1)  ·  auricularum (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)  ·  fludarabine (1)  ·  ixazomib (1)

Sponsors

Mayo Clinic (1)  ·  Tongji Hospital (1)  ·  Zhejiang University (1)

Countries

China (2)  ·  United States (1)

Top investigators

Angela Dispenzieri, M.D. (1)  ·  He Huang, PhD (1)  ·  Wei Wang, MD (1)

Results publications

PMID 37658205, PMID 40425008, PMID 41101309